![](https://i.imgur.com/CLvY2jA.png")
22-02-2022, 10:13 PM
Analysts buoyant on Genting's prospects on gradual reopening after FY2021 dividend disappoints
Analysts from DBS Group Research and UOB Kay Hian are remaining buoyant on Genting Singapore’s prospects as Singapore gradually reopens its borders. Their optimism also comes despite the group’s 4QFY2021 results and dividend for the FY2021 coming in below expectations.
DBS analyst Jason Sum has kept “buy” on the counter with an unchanged target price of $1.
“We believe it is the right time to accumulate Genting Singapore given the clarity on Singapore’s reopening roadmap and the government’s commitment to radically simplify domestic Covid-19 measures,” he writes in his Feb 18 report.
To Sum, Genting Singapore’s current share price levels are a “good entry point” as the stock’s valuation is still cheap at 9.6 times EV/EBITDA (FY2022), compared to the regional peer average of 20.5 times.
https://www.theedgesingapore.com/capital...1-dividend
Analysts from DBS Group Research and UOB Kay Hian are remaining buoyant on Genting Singapore’s prospects as Singapore gradually reopens its borders. Their optimism also comes despite the group’s 4QFY2021 results and dividend for the FY2021 coming in below expectations.
DBS analyst Jason Sum has kept “buy” on the counter with an unchanged target price of $1.
“We believe it is the right time to accumulate Genting Singapore given the clarity on Singapore’s reopening roadmap and the government’s commitment to radically simplify domestic Covid-19 measures,” he writes in his Feb 18 report.
To Sum, Genting Singapore’s current share price levels are a “good entry point” as the stock’s valuation is still cheap at 9.6 times EV/EBITDA (FY2022), compared to the regional peer average of 20.5 times.
https://www.theedgesingapore.com/capital...1-dividend
